Perbedaan Jakarta International Hotels Development Tbk dan Organon Pharma Indonesia Tbk.: Jakarta International Hotels Development Tbk diperdagangkan di Rp450 (kapitalisasi pasar 1,05 T, volume 24 jam 73,6 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jakarta International Hotels Development Tbk jauh lebih besar — sekitar 10,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| JIHD | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,05 T | 104,4 M |
Volume | 73,6 rb | — |
Lot | 736 | — |
Perputaran | 33,02 jt | — |
Harga Rata-rata | 448,66 | — |
Nilai Transaksi | 33,02 jt | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Jakarta International Hotels and Development Tbk (the Company) was established on November 7, 1967. The Company is the owner of Hotel Borobudur (“the Hotel”) which had been managed and operated by Inter-Continental Hotels (Indonesia) BV (Operator) until December 31, 1998. Starting January 1, 1999, the Hotel has been operated by PT Dharma Harapan Raya 60% of whose shares are owned by the Company.
Selengkapnya di halaman JIHD →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →